A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting

A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting

Abstract Introduction This systematic review and meta‐analysis aims to investigate the mutual impact of COVID‐19 and psoriasis to inform clinical practice and future research. Methods We followed the Preferred Reporting Items for Systematic Reviews and Meta‐analysis protocol for systematic reviews a...

Full description

Bibliographic Details
Main Authors:	Nazila Ghoreishi Amin, Sepehr Khosravi, Najmolsadat Atefi, Farnoosh Seirafianpour, Sahand Farhoodi, Azadeh Goodarzi
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Series:	Immunity, Inflammation and Disease
Subjects:	biologics COVID‐19 cytokine storm dermatology flare‐up hyperinflammation
Online Access:	https://doi.org/10.1002/iid3.1063

Similar Items

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

Calcineurin inhibitors revisited: A new paradigm for COVID-19?
by: René Hage, et al.
Published: (2020-07-01)

Light as a Cure in COVID-19: A Challenge for Medicine
by: Laura Marinela Ailioaie, et al.
Published: (2022-09-01)

COVID‐19: lambda interferon against viral load and hyperinflammation
by: Evangelos Andreakos, et al.
Published: (2020-06-01)

New onset and exacerbation of psoriasis after COVID-19 vaccination
by: Nancy Wei, BA, et al.
Published: (2022-01-01)

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
by: Chenliang Ge, et al.
Published: (2020-09-01)

Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19
by: René Hage, et al.
Published: (2021-06-01)

Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters
by: Emmanouil Karampinis, et al.
Published: (2024-02-01)

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
by: Li Yin Tan, et al.
Published: (2021-09-01)

The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
by: Aliakbar Hasankhani, et al.
Published: (2023-02-01)

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation
by: Md Mohosin Rana
Published: (2020-09-01)

Predictors of Duration of Hospital Stay in COVID-19 Disease: A Retrospective Study
by: KP Vijayalakshmi, et al.
Published: (2022-10-01)

Dermatologists’ attitude towards psoriasis treatment during the COVID-19 pandemic
by: Tiago Torres, et al.
Published: (2021-06-01)

Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
by: Robert Root-Bernstein
Published: (2021-02-01)

Immunopathogenesis of COVID-19: Summary and Possible Interventions
by: Francois Henri Jacques, et al.
Published: (2020-09-01)

An Psoriasis in HIV patients: A paradox
by: Damayanti, Nita, et al.
Published: (2022)

Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients
by: Tamara Seitz, et al.
Published: (2022-07-01)

Anti-CD6 humanized monoclonal antibody itolizumab, halts disease progression and severity of acute respiratory distress syndrome in COVID-19 disease: A case study
by: Hemant P Thacker, et al.
Published: (2021-01-01)

COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
by: Carlo Contini, et al.
Published: (2020-08-01)

Three-month follow-up after severe COVID-19 infection: are chest CT results associated with respiratory outcomes and respiratory recovery in COVID-19 patients?
by: Marlou THF Janssen, et al.
Published: (2023-03-01)

N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study
by: Najmolsadat Atefi, et al.
Published: (2020-01-01)

Changes in the Cytokine Profile in Patients During COVID-19 Infection
by: Ivanov N., et al.
Published: (2023-12-01)

Topical treatment of psoriasis
by: Sylwia Skwira, et al.
Published: (2022-12-01)

Clinical management of psoriasis patients during the COVID-19 pandemic
by: Vipawee S. Chat, et al.
Published: (2022-02-01)

COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm
by: Cirino Botta, et al.
Published: (2021-01-01)

Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation
by: Enrique Alfaro, et al.
Published: (2022-03-01)

Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis–A case series and mini review
by: Sascha Ständer, et al.
Published: (2022-09-01)

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
by: Luca Potestio, et al.
Published: (2023-08-01)

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients
by: Kiarash Saleki, et al.
Published: (2022-08-01)

Psoriasis in HIV patients: A paradox
by: Damayanti, Nita, et al.
Published: (2022)

Clinical profile and response to treatment of patients with psoriasis seen via teledermatology during the COVID-19 pandemic in the Philippines
by: Patricia Anne Tinio, MD, et al.
Published: (2022-06-01)

Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19
by: Matthias H. Busch, et al.
Published: (2022-12-01)

Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
by: Afsaneh Sadeghzadeh-Bazargan, et al.
Published: (2023-05-01)

Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial
by: Najmolsadat Atefi, et al.
Published: (2023-11-01)

Immunomodulators and SARS-CoV-2: Management of the Dysregulated Immune Response
by: Chandramouli Mandya Thimmaiah, et al.
Published: (2023-04-01)

Erythrodermic flare‐up of psoriasis with COVID‐19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID‐19 on each other along with the special challenges of the pandemic
by: Elham Behrangi, et al.
Published: (2022-04-01)

Abnormal lipid metabolism in epidermal Langerhans cells mediates psoriasis-like dermatitis
by: Xilin Zhang, et al.
Published: (2022-07-01)

Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update – February 2021
by: Magdalena Okarska-Napierała, et al.
Published: (2021-07-01)

Monocytes and Macrophages in COVID-19
by: Rainer Knoll, et al.
Published: (2021-07-01)

Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid‐19 pandemic: A UK dermatology tertiary centre experience
by: S. Khan, et al.
Published: (2021-09-01)